id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2015-D-2818-0001,FDA,FDA-2015-D-2818,"Rare Diseases: Common Issues in Drug Development; Draft Guidance for
Industry; Availability",Notice,Notice of Availability,2015-08-17T04:00:00Z,2015,8,2015-08-17T04:00:00Z,2015-10-17T03:59:59Z,2015-10-17T01:30:18Z,2015-20235,0,0,0900006481c24984
FDA-2015-D-2818-0002,FDA,FDA-2015-D-2818,Draft Guidance for  Rare Diseases: Common Issues in Drug Development Guidance for Industry,Other,Guidance,2015-08-17T04:00:00Z,2015,8,2015-08-17T04:00:00Z,,2019-08-21T18:45:44Z,,0,0,0900006481c25389